Biomarker for diagnosis and prognosis of Multiple Sclerosis (MS)

Patent number:

EP24382907

No items found.

Countries:

Spain

Regions:

Community of Madrid

Centers:

CSIC, UNIVERSIDAD AUTONOMA DE MADRID, CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Novel biomarker for diagnosis and prognosis - Minimally invasive method through blood or CFS extraction - Known molecular mechanism of action - Novel pre-clinical model for MS

Comments

Other related patents

Health

Allosteric inhibitors of Akt protein for the treatment of Leishmaniasis and Chagas disease.

Countries

Colombia

Health

ANTISEPTIC COMPOSITION CONTAINING 9-HYDROXYCALABAXANTHONE

Countries

Spain

Health

ATR inhibitors

Countries

Spain

Get back to patents directory